肺栓塞患者的临床治疗体会

The Clinical Treatment Experience of Patients with Pulmonary Embolism

目的：观察肺栓塞患者的临床治疗方法和效果。方法搜集2013年8月～2014年8月我院接收的肺栓塞69例患者，按照治疗方法不同分为观察组与对照组。对对照组33例联合应用低分子肝素和华法林，对观察组36例联合应用低分子肝素、华法林和尿激酶。观察对照组与观察组的治疗效果，并比较。结果与对照组相比，观察组指标改善情况较好，治疗有效率较高，有明显差异，有统计学意义（P〈0.05）。结论对肺栓塞患者联合应用低分子肝素、华法林和尿激酶进行治疗，效果确切，应予以重视。

Objective The clinical treatment method and treatment efficacy of patients with pulmonary embolism are to be investigated. Methods Choose 69 patients of pulmonary embolism who are treated in hospital from August 2013 to August 2014 and separate them into study group and control group according to different treatment methods. 33 patients in control group are given low molecular heparin and warfarin treatment; while 36 patients in study group are given combined treatment of low molecular heparin,warfarin and urokinase. And then observe and compare treatment efficacy of two groups. Results Compared to control group,the relevant indicators in study group are improved better,and the treatment efficacy in study group is much higher than control group. There is a treatment differential between two groups,and such a differential has statistic value（P〈0.05）. Conclusion Combined treatment of low molecular heparin, warfarin and urokinase is quite effective to cure patients of pulmonary embolism,and such a treatment approach is suggested to be attached importance.